ClinicalTrials.govpublic full text
Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)
primary open-angle glaucoma (poag), glaucoma, glaucomatous optic neuropathy (gon), mitochondrial dysfunction, neuroprotection, retiniprotection, mexidol, ethylmethylhydroxypyridine succinate, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846133
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.